Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Maud Jost"'
Autor:
Jonathan Douxfils, Jean-Michel Foidart, Ulysse Gaspard, Guillaume Chatel, Mélanie Taziaux, Maud Jost, Céline Gérard, Laure Morimont
Publikováno v:
Menopause Review, Vol 22, Iss 2, Pp 117-119 (2023)
Externí odkaz:
https://doaj.org/article/ef2d6b4114c641278fd272f6288e556a
Autor:
Catherine Maillard, Maud Jost, Maria Unni Rømer, Nils Brunner, Xavier Houard, Annabelle Lejeune, Carine Munaut, Khalid Bajou, Laurence Melen, Keld Dano, Peter Carmeliet, Norbert E. Fusenig, Jean Michel Foidart, Agnès Noel
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 7, Iss 1, Pp 57-66 (2005)
Angiogenesis and tumor expansion are associated with extracellular matrix remodeling and involve various proteases such as the plasminogen (Pig)/plasminogen activator (PA) system. Recently, several experimental data have implicated the plasminogen ac
Externí odkaz:
https://doaj.org/article/89598f6e32274590a1d71f6d2b22a9e8
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 45:349-350
Autor:
Céline Gérard, Jean-François Arnal, Maud Jost, Jonathan Douxfils, Françoise Lenfant, Coralie Fontaine, René Houtman, David F. Archer, Robert L. Reid, Rogerio A. Lobo, Ulysse Gaspard, Herjan J.T. Coelingh Bennink, Mitchell D. Creinin, Jean-Michel Foidart
Publikováno v:
Expert review of clinical pharmacology, vol 15, iss 2
Gerard, C, Arnal, J-F, Jost, M, Douxfils, J, Lenfant, F, Fontaine, C, Houtman, R, Archer, D F, Reid, R L, Lobo, R A, Gaspard, U, Coelingh Bennink, H J T, Creinin, M D & Foidart, J-M 2022, ' Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause ', Expert review of clinical pharmacology, vol. 15, no. 2, pp. 121-137 . https://doi.org/10.1080/17512433.2022.2054413
Gerard, C, Arnal, J-F, Jost, M, Douxfils, J, Lenfant, F, Fontaine, C, Houtman, R, Archer, D F, Reid, R L, Lobo, R A, Gaspard, U, Coelingh Bennink, H J T, Creinin, M D & Foidart, J-M 2022, ' Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause ', Expert review of clinical pharmacology, vol. 15, no. 2, pp. 121-137 . https://doi.org/10.1080/17512433.2022.2054413
Introduction: Estrogens used in women’s healthcare have been associated with increased risks of venous thromboembolism (VTE) and breast cancer. Estetrol (E4), an estrogen produced by the human fetal liver, has recently been approved for the first t
Autor:
Andrew M. Kaunitz, Sharon L. Achilles, János Zatik, Steven Weyers, Terhi Piltonen, Larisa Suturina, Inna Apolikhina, Celine Bouchard, Melissa J. Chen, Jeffrey T. Jensen, Carolyn L. Westhoff, Maud Jost, Jean Michel Foidart, Mitchell D. Creinin
Publikováno v:
CONTRACEPTION
ObjectiveTo evaluate the bleeding patterns of a new combined oral contraceptive containing estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg in a 24/4-day regimen.Study designWe pooled bleeding data from two parallel, open-label, 13-cycle phase 3 trials t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e2326ee35e23149a2f395882c3491fc
https://escholarship.org/uc/item/833253q1
https://escholarship.org/uc/item/833253q1
Autor:
Denise Black, Celine Gerard, Maud Jost, Melanie Taziaux, Guillaume Chatel, Ulysse Gaspard, Jean-Michel Foidart
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 45:349
Autor:
Ingrid Duijkers, Marie Mawet, Christine Klipping, Jean-Michel Foidart, Adriana Bastidas, Catherine Maillard, Maud Jost
Publikováno v:
Contraception. 103:213-221
Objectives To evaluate the effect on endocrine and metabolic parameters of a new combined oral contraceptive (COC) containing estetrol (E4) and drospirenone (DRSP). Study design Randomized, open-label, controlled, 3-arm, parallel study. Healthy subje
Autor:
Jan Rosing, Marie Mawet, Maud Jost, Christine Klipping, Catherine Maillard, Jonathan Douxfils, Jean-Michel Foidart, I.J.M. Duijkers, Virginie Kinet
Publikováno v:
Contraception, 102(6), 396-402. Elsevier Science
Objective: To assess the effect on hemostasis parameters of a new combined oral contraceptive (COC). Study design: In this randomized, single centre, open-label, exploratory study, healthy women received either 15 mg estetrol/3 mg drospirenone (E4/DR
Autor:
Amanda Black, Jeffrey Jensen, Andrew Kaunitz, Melissa Chen, Maud Jost, Jean-Michel Foidart, Mitchell Creinin
Publikováno v:
Journal of Obstetrics and Gynaecology Canada. 44:602-603